CAS 1093740-20-5

N2-[(2R)-4-[(1,1-Dimethylethoxy)amino]-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl]sulfonyl]amino]iminoethyl-L-ornithine

Kontrolliertes Produkt

CAS: 1093740-20-5

Applications Intermediate in the synthesis of substrate-selective peptide hydroxamate inhibitor of insulin-degrading enzyme, N2-[(2R)-4-(Hydroxyamino)-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-L-arginyl-L-tryptophyl-L-α-glutamine (H828110).
References Abdul-Hay, S.O., et al.: J. Med. Chem., 56, 2246 (2013);

Formel: C₃₈H₅₁N₅O₈S

Farbe und Form: Neat

Molekulargewicht: 737.91

Ref: TR-D472945

(2S)-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]-2-[[(2R)-4-[(2-methylpropan-2-yl)oxyamino]-2-(naphthalen-2-ylmethyl)-4-oxobutanoyl]amino]pentanoic acid

CAS: 1093740-20-5

Formel: C₃₈H₅₁N₅O₈S

Molekulargewicht: 737.91

Ref: ST-EA-CP-G54020